Dipyridamole
12 NDCs across 3 manufacturers|12 Generic,0 Brand
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 22, 1986, and the first generic was approved Jul 12, 1990. FDA's Orange Book lists 15 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $1 million on Dipyridamole across 12,000 claims for 2,910 beneficiaries.
Dipyridamole is available as 12 NDCs from 3 manufacturers (12 generic, 0 brand), with NADAC prices from $0.10 to $0.36 per EA — the most expensive product costs about 3.7× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
12
12G / 0B
Manufacturers
3
competing in market
Price Spread
$0.10 – $0.36
per EA
7d Activity
avg -9.1% WoW · of 12 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Platelet Aggregation Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing DIPYRIDAMOLE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
DIPYRIDAMOLE 50 MG TABLET | $0.3573 per EA | -1.38% |
DIPYRIDAMOLE 50 MG TABLET | $0.3573 per EA | -1.38% |
DIPYRIDAMOLE 50 MG TABLET | $0.3573 per EA | -1.38% |
DIPYRIDAMOLE 75 MG TABLET | $0.2720 per EA | — |
DIPYRIDAMOLE 50 MG TABLET | $0.2691 per EA | — |
DIPYRIDAMOLE 75 MG TABLET | $0.2358 per EA | — |
DIPYRIDAMOLE 75 MG TABLET | $0.2358 per EA | — |
DIPYRIDAMOLE 75 MG TABLET | $0.2358 per EA | — |
DIPYRIDAMOLE 25 MG TABLET | $0.1359 per EA | -16.82% |
DIPYRIDAMOLE 25 MG TABLET | $0.1359 per EA | -16.82% |
DIPYRIDAMOLE 25 MG TABLET | $0.1359 per EA | -16.82% |
DIPYRIDAMOLE 25 MG TABLET | $0.0968 per EA | — |
Frequently Asked Questions
When did Dipyridamole become available as a generic?
FDA approved the first generic Dipyridamole (ANDA) on Jul 12, 1990. The Orange Book currently lists 15 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Dipyridamole?
In 2024, Medicare Part D spent $1 million on Dipyridamole across 12,000 claims for 2,910 beneficiaries.
How many Dipyridamole products are on the market?
The Dipyridamole drug market contains 12 NDCs from 3 manufacturers — 12 generic and 0 brand products.
What is the price range for Dipyridamole?
NADAC reference prices for Dipyridamole range from $0.0968 to $0.3573 per EA — the most expensive product costs about 3.7× the cheapest.
Which manufacturers make Dipyridamole?
3 manufacturers list Dipyridamole in NADAC. Ranked by number of NDCs, the largest are Zydus Pharmaceuticals (USA) Inc. (6), Oxford Pharmaceuticals, LLC (3), Amneal Pharmaceuticals of New York LLC (3).
How has the price of Dipyridamole changed recently?
Over the past 7 days, 0 Dipyridamole NDCs rose and 6 fell, with a market-wide average change of -9.1%.